APA (7th ed.) Citation

A, N., N, M., M, A., S, X., AM, B., H, B., . . . G, G. (2026). EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma. Science translational medicine, 18(857), eadx8398. https://doi.org/10.1126/scitranslmed.adx8398

Chicago Style (17th ed.) Citation

A, Nayab, et al. "EGFR Inhibition Down-regulates MGMT and Enhances Responsiveness to Temozolomide in Glioblastoma." Science Translational Medicine 18, no. 857 (2026): eadx8398. https://doi.org/10.1126/scitranslmed.adx8398.

MLA (9th ed.) Citation

A, Nayab, et al. "EGFR Inhibition Down-regulates MGMT and Enhances Responsiveness to Temozolomide in Glioblastoma." Science Translational Medicine, vol. 18, no. 857, 2026, p. eadx8398, https://doi.org/10.1126/scitranslmed.adx8398.